|4Dec 28, 6:42 PM ET

Feldmann Marc 4

4 · 180 Life Sciences Corp. · Filed Dec 28, 2023

Insider Transaction Report

Form 4
Period: 2023-12-28
Feldmann Marc
Director10% Owner
Transactions
  • Award

    Common Stock

    2023-12-28+135,377250,874 total
Footnotes (1)
  • [F1]Granted to the Reporting Person pursuant to the Issuer's equity compensation plans in consideration for services rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.

Documents

1 file
  • 4
    ownership.xmlPrimary